News

Dana Boucher found relief with LUTATHERA, a targeted radioactive therapy specifically for neuroendocrine tumors (NETs) found in the gut or pancreas.

In 2023, an emergency colonoscopy led to Michael's diagnosis of stage 3 cancer. Because of his experience, Michael Kathrens, 70, advocates for proactive health screenings and being an advocate for your own health.

Nellie Jo Gaston received a lifesaving surgery after an abnormal result from an at-home colon cancer screening test. After treatment at Saint Luke’s, she is cancer-free.

Weeks shy of the bar exam, the trajectory of Jackson’s life was rocked off course when he was diagnosed with stage 3 colon cancer. The 26-year-old’s diagnosis was an obstacle that he refused to let topple him.

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

Jackson Auer was two days away from his 26th birthday when he was diagnosed with stage 3 colon cancer. 10 months later, Jackson is now cancer-free, newly engaged, and hoping to raise awareness of the disease.

According to the American Cancer Society, those under the age of 50 are experiencing an increase in colorectal cancer diagnoses, but also an increase in colorectal cancer deaths.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.